Comment by
Noteable on Apr 06, 2024 10:04am
"Registration enabling campaign for accelerated development" is a program that Roche / Genentech employs https://dc.engconfintl.org/ccexvi/241/
Comment by
Noteable on Apr 06, 2024 11:21am
Sierra Oncology was subsequently acquired by GSK in 2022.
Comment by
Noteable on Apr 06, 2024 12:52pm
Quote: " If a human clinical study is denominated not a Phase 3 Clinical Study (for example, human clinical studies formally registered as Phase 2 clinical studies) then it shall only be treated as a Registration Enabling Trial ."
Comment by
Noteable on Apr 06, 2024 2:27pm
Yes I totally agree with you Azzak34 ... "we're not running a phase 3 to sit and wait until the end of it to submit for approval or decide next steps ... We're full steam ahead to get this to market. "
Comment by
Noteable on Apr 06, 2024 7:14pm
" The path we're on makes everyone, who actually has shares, a lot of money in the near to mid term." Agreed Azzak34
Comment by
Noteable on Apr 07, 2024 3:32pm
And just as a reminder .." The path we're on makes everyone, who actually has shares, a lot of money in the near to mid term."
Comment by
Buckhenry on Apr 06, 2024 10:33pm
Something will have to happen one way or another in the near term... they are running out of money. Clocks ticking dude.
Comment by
Peladawn on Apr 06, 2024 11:24pm
Wow! You figured that out all by yourself, Bucky?!
Comment by
Lesalpes29 on Apr 07, 2024 10:01am
Reading in it a very good development. Maybe just maybe with ower future partner (BP like Roche!) to support us and to help us. Have a good sunday,
Comment by
Buckhenry on Apr 07, 2024 11:27am
This post has been removed in accordance with Community Policy
Comment by
Peladawn on Apr 07, 2024 11:58am
Yes, and apparently you didn't even have to finish sixth grade, either.
Comment by
Buckhenry on Apr 07, 2024 12:30pm
How did you know that peladuffus? MIT recruited me into their engineering program before I finished the 6th grade.
Comment by
Azzak34 on Apr 07, 2024 12:38pm
Bucky does the I stand for illiterate?
Comment by
Peladawn on Apr 07, 2024 1:02pm
Although that is incredibly hard to believe, it could certainly be possible, concidering MIT's use of their woke DEI Program that provides scholarships for the intellectually challenged.
Comment by
Peladawn on Apr 07, 2024 1:06pm
Especially since you were the only 21 year old in your sixth grade class.
Comment by
Buckhenry on Apr 07, 2024 3:44pm
This post has been removed in accordance with Community Policy
Comment by
Azzak34 on Apr 07, 2024 3:54pm
It's weird you know the process for that!
Comment by
Buckhenry on Apr 07, 2024 4:01pm
The reason I know is I give back to my community to help those less fortunate to try and become better people and an asset to their community. Maybe you get your GED you could one day become an asset instead of a liability in your community assak.
Comment by
Buckhenry on Apr 08, 2024 12:45pm
One would think after all the endless pumping by pumpers anonymous on here in the last several years this stock would be bought out or at least $20 a share. Guess the market is not paying much attention here. Maybe if the pumpers could put in a little more zeal in their post we can get there. But I'm sure prosperity is just around the corner.....
Comment by
Noteable on Apr 07, 2024 2:42pm
And your "trigger-happy" opinion inthno, is as bad as this last post of yours, since very little of what you say "holds water", and you have never provided any proof to what you say, when asked. So inthno, you are as phoney as a $3 bill.
Comment by
inthno on Apr 07, 2024 2:43pm
at least a 3 dollar phoney bill is worth more than a share of onc right now.
Comment by
Azzak34 on Apr 07, 2024 2:46pm
See, it wouldn't be because it's a phony $3 bill. You can sell right now and gosh darn it I wish you would. I hear Crispr is doing great, try that.
Comment by
Noteable on Apr 08, 2024 8:32pm
Quentin30 it's surprising how out of date you are concerning ONCY, especially now that Big Pharma is beginning to successfully report on their research with mRNA vaccines in pancreatic cancer, thus opening the vaccine/OV space for further investment dollars and acquisitions of companies currently opening up this novel 4th pillar of cancer treatment area of cancer immunotherapeutics.
Comment by
Noteable on Apr 08, 2024 8:50pm
Should read: crispr stock is down to $64 from a high of $200.
Comment by
Noteable on Apr 08, 2024 9:13pm
Additionally, and as importantly, ONCY's oncolytic virus pelareorep is administered through intravenous (IV) injection rather than intratumoral (IT) injection, which is the route most other oncolytic viruses are administered. Consequently ONCY's pelareorep has few OV competitors since IV administration is the route that Big Pharma wants. And not IT.
Comment by
Noteable on Apr 07, 2024 3:01pm
'Trigger Happy" and Phoney inthno would have you buying a phoney $3 bill than one share of ONCY. So he has unwittingly revealed his purpose for being here.
Comment by
Noteable on Apr 07, 2024 1:38pm
inthno wrote ... "As for AA, yes I do not think it is possible at this point in time or it would have happened by now..." REALLY? Tell us why. You obviously didn't or couldn't understand the reasoning so far.